Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Therapeutic applications of vitamin D analogues.

× No keyword cloud information.

15 in total

1. Vitamin-D-dependent rickets type II. Resistance of target organs to 1,25-dihydroxyvitamin D.

Authors: M H Brooks; N H Bell; L Love; P H Stern; E Orfei; S F Queener; A J Hamstra; H F DeLuca
Journal: N Engl J Med Date: 1978-05-04 Impact factor: 91.245

2. Increased growth after long-term oral 1alpha,25-vitamin D3 in childhood renal osteodystrophy.

Authors: R W Chesney; A V Moorthy; J A Eisman; D K Jax; R B Mazess; H F DeLuca
Journal: N Engl J Med Date: 1978-02-02 Impact factor: 91.245

3. The absence of 24,25-dihydroxycholecalciferol in anephric patients.

Authors: C M Taylor; E B Mawer; J E Wallace; J St John; M Cochran; R G Russell; J A Kanis
Journal: Clin Sci Mol Med Suppl Date: 1978-12

4. Vitamin D deficiency and bone disease in gastrointestinal disorders.

Authors: M Sitrin; S Meredith; I H Rosenberg
Journal: Arch Intern Med Date: 1978-05-15

5. Vitamin D metabolites and bone mineralization in man.

Authors: P Bordier; H Rasmussen; P Marie; L Miravet; J Gueris; A Ryckwaert
Journal: J Clin Endocrinol Metab Date: 1978-02 Impact factor: 5.958

6. The continuing risk of vitamin-D intoxication.

Authors: M Davies; P H Adams
Journal: Lancet Date: 1978-09-16 Impact factor: 79.321

7. 1, 25-dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosis.

Authors: S E Papapoulos; T L Clemens; L J Fraher; I G Lewin; L M Sandler; J L O'Riordan
Journal: Lancet Date: 1979-03-24 Impact factor: 79.321

8. Deterioration of renal function during treatment of chronic renal failure with 1,25-dihydroxycholecalciferol.

Authors: C Christiansen; P Rødbro; M S Christensen; B Hartnack; I Transbøl
Journal: Lancet Date: 1978-09-30 Impact factor: 79.321

9. Comparison of oral 25-hydroxycholecalciferol, vitamin D, and ultraviolet light as determinants of circulating 25-hydroxyvitamin D.

Authors: T C Stamp; J G Haddad; C A Twigg
Journal: Lancet Date: 1977-06-25 Impact factor: 79.321

10. Treatment of renal bone disease with 1 alpha-hydroxylated derivatives of vitamin D3. Clinical, biochemical, radiographic and histological responses.

Authors: J A Kanis; T Cundy; M Earnshaw; R G Henderson; G Heynen; R Naik; R G Russell; R Smith; C G Woods
Journal: Q J Med Date: 1979-04

2 in total

1. Transplacental transfer of 25-hydroxy-cholecalciferol.

Authors: M M Gupta; G Kuppuswamy; A R Subramanian
Journal: Postgrad Med J Date: 1982-07 Impact factor: 2.401

Review 2. Vitamin therapy in the absence of obvious deficiency. What is the evidence?

Authors: L Ovesen
Journal: Drugs Date: 1984-02 Impact factor: 9.546

2 in total